Complement regulation: physiology and disease relevance

作者: Heeyeon Cho

DOI: 10.3345/KJP.2015.58.7.239

关键词:

摘要: The complement system is part of the innate immune response and as such defends against invading pathogens, removes complexes damaged self-cells, aids organ regeneration, confers neuroprotection, engages with adaptive via T B cells. Complement activation can either benefit or harm host organism; thus, must maintain a balance between on foreign modified self surfaces inhibition intact regulators are essential for maintaining this classified soluble regulators, factor H, membrane-bound regulators. Defective damage cell result in accumulation immunological debris. Moreover, defective associated several autoimmune diseases atypical hemolytic uremic syndrome, dense deposit disease, age-related macular degeneration, systemic lupus erythematosus. Therefore, understanding molecular mechanisms by which regulated important development novel therapies complement-associated diseases.

参考文章(38)
Daniel Turnberg, Margarita Lewis, Jill Moss, Yuanyuan Xu, Marina Botto, H. Terence Cook, Complement Activation Contributes to Both Glomerular and Tubulointerstitial Damage in Adriamycin Nephropathy in Mice Journal of Immunology. ,vol. 177, pp. 4094- 4102 ,(2006) , 10.4049/JIMMUNOL.177.6.4094
W. Haller, D. V. Milford, T. H. J. Goodship, K. Sharif, D. F. Mirza, P. J. McKiernan, Successful Isolated Liver Transplantation in a Child with Atypical Hemolytic Uremic Syndrome and a Mutation in Complement Factor H American Journal of Transplantation. ,vol. 10, pp. 2142- 2147 ,(2010) , 10.1111/J.1600-6143.2010.03228.X
Hee Yeon Cho, Byong Sop Lee, Kyung Chul Moon, Il Soo Ha, Hae Il Cheong, Yong Choi, Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate Pediatric Nephrology. ,vol. 22, pp. 874- 880 ,(2007) , 10.1007/S00467-007-0438-X
V.Michael Holers, The complement system as a therapeutic target in autoimmunity. Clinical Immunology. ,vol. 107, pp. 140- 151 ,(2003) , 10.1016/S1521-6616(03)00034-2
Peter F Zipfel, Stefan Heinen, Mihály Józsi, Christine Skerka, None, Complement and diseases: defective alternative pathway control results in kidney and eye diseases. Molecular Immunology. ,vol. 43, pp. 97- 106 ,(2006) , 10.1016/J.MOLIMM.2005.06.015
Sibylle Tschumi, Mathias Gugger, Barbara S. Bucher, Magdalena Riedl, Giacomo D. Simonetti, Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings Pediatric Nephrology. ,vol. 26, pp. 2085- 2088 ,(2011) , 10.1007/S00467-011-1989-4
Matthew Pickering, H Terence Cook, Complement and glomerular disease: new insights Current Opinion in Nephrology and Hypertension. ,vol. 20, pp. 271- 277 ,(2011) , 10.1097/MNH.0B013E328345848B
Katherine A. Vernon, H. Terence Cook, Complement in Glomerular Disease Advances in Chronic Kidney Disease. ,vol. 19, pp. 84- 92 ,(2012) , 10.1053/J.ACKD.2012.02.015
Sanjeev Sethi, Fernando C Fervenza, Yuzhou Zhang, Richard JH Smith, None, Secondary Focal and Segmental Glomerulosclerosis Associated With Single-Nucleotide Polymorphisms in the Genes Encoding Complement Factor H and C3 American Journal of Kidney Diseases. ,vol. 60, pp. 316- 321 ,(2012) , 10.1053/J.AJKD.2012.04.011
David D. Kim, Wen-Chao Song, Membrane complement regulatory proteins. Clinical Immunology. ,vol. 118, pp. 127- 136 ,(2006) , 10.1016/J.CLIM.2005.10.014